NCT04564625

Brief Summary

Vitamin D is an essential hormone involved in bone metabolism, bone mineral density maintenance, and bone health. Vitamin D deficiency is putatively linked to poor pediatric orthopedic outcomes \[1\]. Further, the risk of low vitamin D associated fractures may be greater in minority pediatric populations \[2\]. In adults, utility of vitamin D alleles as a biomarker for bone density and fracture risk has been debated for over 10 years \[3-5\]. Peak bone density is achieved at 25 years old; however, most orthopedic trauma patients less than 25 years of age present with substantial vitamin D deficiencies.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 21, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 25, 2020

Completed
2.5 years until next milestone

Study Start

First participant enrolled

March 20, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2024

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2024

Completed
Last Updated

July 7, 2023

Status Verified

July 1, 2023

Enrollment Period

11 months

First QC Date

September 21, 2020

Last Update Submit

July 6, 2023

Conditions

Keywords

fracturefracture nonunionvitamin D

Outcome Measures

Primary Outcomes (1)

  • Vitamin D levels at the time of the index injury through one year post-operative follow up.

    Vitamin D levels at the time of the index injury through one year post-operative follow up.

    February 2016 and February 2020

Secondary Outcomes (7)

  • Patient demographics

    February 2016 and February 2020

  • injury characteristics

    February 2016 and February 2020

  • rate of nonunion

    February 2016 and February 2020

  • admit information

    February 2016 and February 2020

  • discharge disposition

    February 2016 and February 2020

  • +2 more secondary outcomes

Study Arms (1)

Fracture and Vitamin D assessment

All patients between 18 and 25 years treated for fractures at Methodist Dallas Medical Center (MDMC) with an index admission vitamin D assessment will be enrolled. This study will consider any patients with an index admission occurring between February 2016 and February 2020. No changes to care or intervention will occur and this study will be conducted completely via chart review. The aim is to identify 100 subjects with a one-year follow-up appointment for their injury to determine the rate of nonunion and vitamin D levels. As patients receive vitamin D supplementation as standard of care if index values are low, impact will be assessed through relative deficiency and clinical outcomes. Data collected from subjects without need for supplementation may be used to generate a threshold.

Other: Vitamin D AssessmentOther: Fracture

Interventions

index admission vitamin D assessment

Fracture and Vitamin D assessment

rate of nonunion (i.e., failure of a fractured bone to heal)

Fracture and Vitamin D assessment

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

All patients between 18 and 25 years treated for fractures at Methodist Dallas Medical Center (MDMC) with an index admission vitamin D assessment will be enrolled. This study will consider any patients with an index admission occurring between February 2016 and February 2020.We will also consider patient demographics as practice suggests minority patients may be disproportionally affected.

You may qualify if:

  • Patients must be \>18 years old and ≤25 years old
  • Patients must have any fracture requiring follow-up
  • Patients must have received vitamin-D assessment

You may not qualify if:

  • Patients aged \>25yrs
  • Prisoners
  • Pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Methodist Health System Clinical Research Institute

Dallas, Texas, 75203, United States

Location

Related Publications (5)

  • Horan MP, Williams K, Hughes D. The Role of Vitamin D in Pediatric Orthopedics. Orthop Clin North Am. 2019 Apr;50(2):181-191. doi: 10.1016/j.ocl.2018.10.002.

    PMID: 30850077BACKGROUND
  • Ramirez N, Ortiz-Fullana JL, Arciniegas N, Fullana A, Valentin P, Orengo JC, Iriarte I, Carlo S. Vitamin D levels and fracture risk among Hispanic children. Eur J Orthop Surg Traumatol. 2019 Apr;29(3):531-536. doi: 10.1007/s00590-018-2315-7. Epub 2018 Oct 13.

    PMID: 30317468BACKGROUND
  • McClean E, Archbold GP, Taggart HM. Do the COL1A1 and Taq 1 vitamin D receptor polymorphisms have a role in identifying individuals at risk of developing osteoporosis? Ulster Med J. 2003 May;72(1):26-33.

    PMID: 12868700BACKGROUND
  • Lorentzon M, Lorentzon R, Nordstrom P. Vitamin D receptor gene polymorphism is associated with birth height, growth to adolescence, and adult stature in healthy caucasian men: a cross-sectional and longitudinal study. J Clin Endocrinol Metab. 2000 Apr;85(4):1666-70. doi: 10.1210/jcem.85.4.6566.

    PMID: 10770213BACKGROUND
  • Ensrud KE, Stone K, Cauley JA, White C, Zmuda JM, Nguyen TV, Eisman JA, Cummings SR. Vitamin D receptor gene polymorphisms and the risk of fractures in older women. For the Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1999 Oct;14(10):1637-45. doi: 10.1359/jbmr.1999.14.10.1637.

    PMID: 10491209BACKGROUND

MeSH Terms

Conditions

Fractures, BoneFractures, Ununited

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Officials

  • Edgar Araiza, MD

    Methodist

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 21, 2020

First Posted

September 25, 2020

Study Start

March 20, 2023

Primary Completion

February 20, 2024

Study Completion

March 20, 2024

Last Updated

July 7, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

This is a single center study and the data will not be shared with outside entities until it is de-identified in order to be presented at relevant conferences or published in a scientific journal

Locations